A leading provider of CMO and R&D services to the top Indian & MNC pharmaceutical companies.

The Acme group began its journey in 2005 with a bold mission of becoming a leader in the contract manufacturing space and a preferred business partner for pharmaceutical companies looking for world class capabilities and scalable operations.

Guided by the founder's vision and purpose, the Acme group, over the years, has scaled new heights in the pharmaceutical value chain and today provides fully integrated contract manufacturing and development solutions to some of the top Indian and global pharmaceutical companies.

Acme strongly believes in fast growth combined with a focus on innovation and service. At present the group consists of four state-of-the-art, fast growing companies viz. Acme Formulation, Immacule, Acme Generics Pvt. Ltd. and Veritas Research.

Powering the group are 2500+ highly skilled staff working in over 500,000 sq.ft manufacturing space across Northern India, producing 17 billion tablets, 3 billion capsules, 30 million ampoules and 12 million Lyo vials. The group has also expanded into niche segments of Oral Hormones, both Sex Hormones and Levothyroxine, along with General Injectables - Liquids and Lyophilized.

In our journey over the past decade we have been audited and approved by various international regulatory agencies including UK-MHRA, EU-GMP, TGA Australia, Health Canada, ANVISA, INVIMA, WHO-Geneva. Apart from this, the group also have International regulatory approvals across major countries in Asia, Africa, CIS and Latin Countries.

Immacule is approved by USFDA since 2019 with 15+ ANDA approved, 30+ ANDA under filing as CDMO as we continue our journey towards building a sustainable future. In 2022, Immacule received EU-GMP accreditation.

Our Vision & Mission

   - To become a globally reputed company in supply of high quality innovative sterile drug products.

   - To develop, register & commercialize maximum generic sterile drug product across all regulated and emerging markets in world.

Acme looks to the future with ever higher goals and ambitions and with its unwavering focus on service and quality is strategically poised to grow even further in the years ahead.

00 Billion
00 Million
00 Billion
00 Million
Lyo Vials